Results from studies in different organ-type cancers including breast cancer indicated that CIP2A, rather than independently/ exclusively accomplishing the tumorigenic effect in cells, forms an important component of the “oncogenic nexus” in concert with PP2A and c-MYC. This evidence concerns the gene CIP2A and cancer.